ABSTRACT The granulocyte colony-stimulating factor (GCSF) regulates the 
Introduction

43
The granulocyte colony-stimulating factor (GCSF) is the principal growth factor 44 that regulates the maturation, proliferation, and differentiation of precursor cells of 45 neutrophilic granulocytes (Nickerson 1991) . The GCSF coding gene is localized on 46 chromosome 11. The GCSF is a member of the long-chain subtype of the class 1 47 cytokine superfamily, which includes growth hormone, erythropoietin, interleukin 6, 48 and oncostatin M. The crystal structure of the GCSF is complexed to the BN-BC 49 4 domains, which is the principal ligand-binding region of the GCSF receptor (GCSFR), 50 and forms a complex at a 2:2 ratio with the ligand. This complex has a non-51 crystallographic pseudo-twofold axis, which primarily runs through the interdomain 52 region and secondarily the BC domain (Aritomi et al. 1999) . The GCSF plays a role 53 in regulating the phosphatidylinositol-3-kinase/serine/threonine kinase (PI3K/AKT) 54 pathway, thus affecting cell proliferation and apoptosis, inducing the expression of the 55 vascular endothelial growth factor (VEGF) (Liang et al. 2018) .
56
Most antibiotics are used for livestock, which is continuously increasing due to 
68
The GCSF has been widely studied in several species (Armenise et China; permit number DK596). 
102
Reagents and kits
RT-PCR and real-time RT-PCR
116
Total RNA of tissues from heart, liver, spleen, lung, kidney, lymph, uterus, ovary, 117 skin, muscles, breast, and hypothalamus were extracted using the TRIzol RNA 
166
The recombinant GCSF proteins in the supernatant were detected by dot blot, were 167 purified using High Affinity Ni-Charged Resin (Nanjing Genscript Biotechnology Co.,
168
Ltd., Nanjing, China, code#L00223), and detected by SDS-PAGE and Western blot.
169
Western blot 170
Full-length sGCSF proteins in the cell culture supernatant or in the purified 171 soluble sGCSF proteins from culture medium were subjected to 12% SDS-PAGE,
172
were then transferred onto nitrocellulose membranes, and blocked with 5% non-fat 
218
The percentage of polymorphonuclear neutrophils (PMN) among leukocytes was 219 manually determined by using wright stained blood smear glass slides that were 220 examined under an Olympus H7 microscope. The absolute neutrophil count (ANC) 221 was determined by multiplying the total WBC count by the PMN percentage.
222
Statistics
223
The significance of differences between groups was assessed using GraphPad 
Results
234
Sequence analysis of sGCSF cDNA 235 The predicted variant sGCSF sequences and an mRNA 3' end sequence are sGCSF has the highest homology (>91%) with Bos taurus, moderate homology 244 (>73%) with human, and low homology with both rattus (>62%) and mouse (>58%).
245
The highly conserved regions were located in the 3' end domains of GCSFs, 246 suggesting that these 3' end domains are important for its functions. RT-PCR analyses ( Figure 2D ). As show in Figure 2A and B, Both GCSFv1 and
260
GCSFv2 had significantly lower expression in lung and hypothalamus, and GCSFv1
261
was significantly highly expressed in breast tissue. These trends were almost stable in 262 other tissues. Quantitative analyses identified higher expression of GCSFv2 than
263
GCSFv1 in all tissues, and the highest expression difference was found in the ovary
264
( Figure 2C ). GCSFv1 and GCSFv2 in different tissues.
271
Molecular cloning, sGCSF proteins expression, and purification
272
The expression plasmids of three types of GCSF proteins (GCSF C-terminal,
273
GCSFv1, and GCSFv2) were expressed in ExpiCHO-S. SDS-PAGE analysis of 274 fractions ( Figure 3A) shows one major band of ~90% abundance in each test, with a 275 molecular mass of ~20 kDa, which was visualized by Coomassie blue staining after purification, corresponding to GCSF C-terminal, GCSFv1, and GCSFv2.
277
The identities of the secreted proteins were confirmed by using both anti-6×His 278 tag and anti-GCSF C-terminal antibodies via Western blot as illustrated in Figure 3 B 
279
and C. Figure 3B shows that the proteins (lanes 1, 2, and 3) were recognized by the 280 anti-6×His tag antibody. Figure 3C shows that the proteins (lanes 1, 2, and 3) were 281 also recognized by an anti-GCSF C-terminal polyclonal antibody. 
In vitro bioassay
290
The biological activities of the purified proteins were assayed for GCSF activity MNFS-60 cell culture medium to replace hMCSF as cell growth factor. As shown in 294 Figure 4 , the biological activities of the GCSF C-terminal, GCSFV1, and GCSFV2
295
were ~44.5/10 th , 1.03/10 th , and 6.78/10 th of that of the commercial hMCSF,
296
respectively. The EC50 of the hMCSF control was ~2.647 ng/ml, while the EC50 of 297 GCSF C-terminal, GCSFV1, and GCSFV2 were 0.5948, 25.58, and 3.905 ng/ml as a
298
GCSF equivalent. These results showed that GCSF C-terminal activity was best. terminal (red), GCSFv1 (green), and GCSFv2 (blue). Cell viability was quantified 304 using an AlamarBlue (Invitrogen) assay.
305
In vivo studies
306
Balb/c mice were injected s.c. with 10 μg/kg GCSF C-terminal, GCSFv1,
307
GCSFv2, or PBS control (ctr). The molecular masses of GCSF C-terminal, GCSFv1,
308
and GCSFv2 were 20, 22, and 25 kDa; therefore, the final dosage for each were 50, treatments with GCSF C-terminal, GCSFv1, and GCSFv2. 
358
The ability to stimulate cell proliferation in vitro was higher for GCSF C-
359
terminal molecules compared with both GCSFv1 and GCSFv2. The in vitro biological 360 activity of the GCSF C-terminal was about 7-50-fold higher than the activities of both
361
GCSFv1 and GCSFv2, which suggests that C-terminal plays an important role in the 
Conclusion
377
The two ovine predicted GCSF variants GCSFv1 and GCSFv2 were cloned. The 
